Small cell lung cancer: updates and new concepts.
作者信息
Ujhazy Peter, Lindwasser O Wolf
机构信息
National Cancer Institute, Bethesda, MD, USA. (Email:
National Cancer Institute, Bethesda, MD, USA.
出版信息
Transl Lung Cancer Res. 2018 Feb;7(1):1-3. doi: 10.21037/tlcr.2018.02.01.
Abstract
摘要
相似文献
1
Small cell lung cancer: updates and new concepts.小细胞肺癌：最新进展与新概念
Transl Lung Cancer Res. 2018 Feb;7(1):1-3. doi: 10.21037/tlcr.2018.02.01.
2
Automated SNOMED CT concept and attribute relationship detection through a web-based implementation of cTAKES.通过基于网络的cTAKES实现自动检测SNOMED CT概念与属性关系
J Biomed Semantics. 2019 Sep 18;10(1):14. doi: 10.1186/s13326-019-0207-3.
3
Non-small cell lung cancer, version 2.2013.非小细胞肺癌临床实践指南（2013 年版）
J Natl Compr Canc Netw. 2013 Jun 1;11(6):645-53; quiz 653. doi: 10.6004/jnccn.2013.0084.
4
Updates in non-small cell lung cancer.非小细胞肺癌的最新进展
Clin J Oncol Nurs. 2008 Aug;12(4):587-96. doi: 10.1188/08.CJON.587-596.
5
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.非小细胞肺癌（NSCLC）的分子诊断与靶向治疗：最新进展
Discov Med. 2019 Mar;27(148):167-170.
6
7
Updates in Lung Cancer Cytopathology.肺癌细胞病理学的进展
Surg Pathol Clin. 2018 Sep;11(3):515-522. doi: 10.1016/j.path.2018.04.004.
8
Small cell lung cancer: updates and future directions.小细胞肺癌：最新进展与未来方向。
J Thorac Dis. 2020 Oct;12(10):6210-6211. doi: 10.21037/jtd.2020.02.62.
9
Pulmonary pathology: new updates.
J Clin Pathol. 2013 Oct;66(10):831. doi: 10.1136/jclinpath-2013-201898.
10
Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.肺癌筛查，版本 1.2015：NCCN 指南的重点更新。
J Natl Compr Canc Netw. 2015 Jan;13(1):23-34; quiz 34. doi: 10.6004/jnccn.2015.0006.
引用本文的文献
1
Antigene Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance.BGA002介导的反基因沉默通过阻断mTOR信号通路抑制小细胞肺癌进展并克服多药耐药
Cancers (Basel). 2023 Feb 3;15(3):990. doi: 10.3390/cancers15030990.
2
Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.抑制核转运蛋白β1介导的核输入会破坏小细胞肺癌中定义致癌谱系的转录因子活性。
Cancer Res. 2022 Sep 2;82(17):3058-3073. doi: 10.1158/0008-5472.CAN-21-3713.
3
Molecular Pathology of Lung Cancer.肺癌的分子病理学
Cold Spring Harb Perspect Med. 2022 Mar 1;12(3):a037812. doi: 10.1101/cshperspect.a037812.
4
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer.EPAC-肺：欧洲对小细胞肺癌中循环肿瘤细胞预后价值的汇总分析。
Transl Lung Cancer Res. 2021 Apr;10(4):1653-1665. doi: 10.21037/tlcr-20-1061.
5
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.定义肿瘤对 PD-1 通路阻断的耐药性：来自 SITC 免疫治疗耐药性工作组第一次会议的建议。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000398.
6
Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.肺神经内分泌肿瘤细胞的亚型特异性分泌组学特征。
Nat Commun. 2019 Jul 19;10(1):3201. doi: 10.1038/s41467-019-11153-5.
7
Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer.肿瘤异质性导致小细胞肺癌小鼠模型对顺铂的敏感性存在差异。
Cell Rep. 2019 Jun 11;27(11):3345-3358.e4. doi: 10.1016/j.celrep.2019.05.057.
本文引用的文献
1
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.膀胱和肺的小细胞癌具有趋同但不同的发病机制。
Clin Cancer Res. 2018 Apr 15;24(8):1965-1973. doi: 10.1158/1078-0432.CCR-17-2655. Epub 2017 Nov 27.
2
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.神经内分泌前列腺癌和原发性小细胞前列腺癌的基因表达特征。
BMC Cancer. 2017 Nov 13;17(1):759. doi: 10.1186/s12885-017-3729-z.
3
Small-cell lung cancer: what we know, what we need to know and the path forward.小细胞肺癌：我们已知的、需要知道的以及未来的发展方向。
Nat Rev Cancer. 2017 Dec;17(12):725-737. doi: 10.1038/nrc.2017.87. Epub 2017 Oct 27.
4
Unravelling the biology of SCLC: implications for therapy.揭示小细胞肺癌的生物学特性：对治疗的启示
Nat Rev Clin Oncol. 2017 Sep;14(9):549-561. doi: 10.1038/nrclinonc.2017.71. Epub 2017 May 23.
5
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.MYC驱动小细胞肺癌向一种对极光激酶抑制敏感的变异神经内分泌亚型发展。
Cancer Cell. 2017 Feb 13;31(2):270-285. doi: 10.1016/j.ccell.2016.12.005. Epub 2017 Jan 12.
6
Small cell lung cancer: Time to revisit DNA-damaging chemotherapy.小细胞肺癌：是时候重新审视DNA损伤性化疗了。
Sci Transl Med. 2016 Jul 6;8(346):346fs12. doi: 10.1126/scitranslmed.aaf6282.
7
Small cell lung cancer (SCLC): no treatment advances in recent years.小细胞肺癌（SCLC）：近年来无治疗进展。
Transl Lung Cancer Res. 2016 Feb;5(1):39-50. doi: 10.3978/j.issn.2218-6751.2016.01.03.
8
Immunotherapy for small-cell lung cancer: emerging evidence.小细胞肺癌的免疫疗法：新出现的证据。
Future Oncol. 2016 Apr;12(7):931-43. doi: 10.2217/fon-2015-0012. Epub 2016 Feb 17.
9
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer.局限期小细胞肺癌的多模态治疗。
J Oncol Pract. 2016 Feb;12(2):111-7. doi: 10.1200/JOP.2015.009068.
10
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?小细胞肺癌：生物学和分子生物学的最新进展能否转化为更好的治疗结果？
J Thorac Oncol. 2016 Apr;11(4):453-74. doi: 10.1016/j.jtho.2016.01.012. Epub 2016 Jan 30.
Zotero 插件